Outputs (2)

First clinical evidence characterizing safety and efficacy of the new CoCr Biolimus-A9 eluting stent: The Biomatrix Alpha™ registry (2020)
Journal Article
Mamas. (2020). First clinical evidence characterizing safety and efficacy of the new CoCr Biolimus-A9 eluting stent: The Biomatrix Alpha™ registry. https://doi.org/10.1016/j.ijcha.2020.100472

Background The biolimus-eluting stent (BES) was the first to elute anti-proliferative drug from a biodegradable polymer. In the randomized LEADERS trial, a stainless steel BES showed non-inferior efficacy compared to a sirolimus-eluting stent and a l... Read More about First clinical evidence characterizing safety and efficacy of the new CoCr Biolimus-A9 eluting stent: The Biomatrix Alpha™ registry.

In-hospital Upper Gastrointestinal Bleeding Following Percutaneous Coronary Intervention (2020)
Journal Article
Zaman, A., Kinnaird, T., Mamas, M., Kontopantelis, E., Potts, J., Ayyaz Ul Haq, M., …Large, A. (2020). In-hospital Upper Gastrointestinal Bleeding Following Percutaneous Coronary Intervention. Catheterization and Cardiovascular Interventions, 109-117. https://doi.org/10.1002/ccd.28222

Objectives This study aims to examine in-hospital gastrointestinal (GI) bleeding, its predictors and clinical outcomes, including long-term outcomes, in a national cohort of patients undergoing percutaneous coronary intervention (PCI) in England and... Read More about In-hospital Upper Gastrointestinal Bleeding Following Percutaneous Coronary Intervention.